These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9787980)

  • 21. Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity.
    Nehra D; Howell P; Williams CP; Pye JK; Beynon J
    Gut; 1999 May; 44(5):598-602. PubMed ID: 10205192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of acid and bile reflux in oesophagitis and Barrett's metaplasia.
    Souza RF
    Biochem Soc Trans; 2010 Apr; 38(2):348-52. PubMed ID: 20298181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux?
    Dixon MF; Neville PM; Mapstone NP; Moayyedi P; Axon AT
    Gut; 2001 Sep; 49(3):359-63. PubMed ID: 11511557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ethiopathogenesis of gastroesophageal reflux disease].
    Lukás K; Marecek P
    Cas Lek Cesk; 2000 Aug; 139(15):455-9. PubMed ID: 22666924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interrelationship between salivary epidermal growth factor and the functional integrity of the esophageal mucosal barrier in the rat.
    Sarosiek J; Feng T; McCallum RW
    Am J Med Sci; 1991 Dec; 302(6):359-63. PubMed ID: 1772120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental columnar metaplasia in the canine oesophagus.
    Gillen P; Keeling P; Byrne PJ; West AB; Hennessy TP
    Br J Surg; 1988 Feb; 75(2):113-5. PubMed ID: 3349294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salivary epidermal growth factor concentration in adults with reflux laryngitis.
    Eckley CA; Michelsohn N; Rizzo LV; Tadokoro CE; Costa HO
    Otolaryngol Head Neck Surg; 2004 Oct; 131(4):401-6. PubMed ID: 15467608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barrett's oesophagus: treatment with surgery.
    DeMeester SR
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):211-7. PubMed ID: 25743467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salivary growth factors and cytokines are not deficient in patients with gastroesophageal reflux disease or Barrett's esophagus.
    Kongara K; Varilek G; Soffer EE
    Dig Dis Sci; 2001 Mar; 46(3):606-9. PubMed ID: 11318540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment of Barrett's oesophagus. A general survey.
    Petrakis IE; Sciacca V; Iascone C
    Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
    Shearer C; Going J; Neilson L; Mackay C; Stuart RC
    Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?
    Fitzgerald RC
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i21-6. PubMed ID: 15711004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac mucosa, Barrett's oesophagus and cancer of the gastro-oesophageal junction: what's in a name?
    Spechler SJ
    Gut; 2017 Aug; 66(8):1355-1357. PubMed ID: 27196579
    [No Abstract]   [Full Text] [Related]  

  • 34. Esophageal mucosal resistance. A factor in esophagitis.
    Goldstein JL; Schlesinger PK; Mozwecz HL; Layden TJ
    Gastroenterol Clin North Am; 1990 Sep; 19(3):565-86. PubMed ID: 2228164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of oesophageal 'alkaline' pH environment in controls and patients with gastro-oesophageal reflux disease.
    Singh S; Bradley LA; Richter JE
    Gut; 1993 Mar; 34(3):309-16. PubMed ID: 8472976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of salivary epidermal growth factor in the pathogenesis of Barrett's columnar lined oesophagus.
    Jankowski J
    Br J Surg; 1992 Jul; 79(7):716. PubMed ID: 1643501
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects.
    Roman S; Kahrilas PJ
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):17-28. PubMed ID: 25743453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acid suppression and surgical therapy for Barrett's oesophagus.
    de Jonge PJ; Spaander MC; Bruno MJ; Kuipers EJ
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):139-50. PubMed ID: 25743462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the magnitude of gastro-oesophageal reflux in Barrett's oesophagus.
    Parrilla P; Ortiz A; Martinez de Haro LF; Aguayo JL; Ramirez P
    Gut; 1990 Sep; 31(9):964-7. PubMed ID: 2210462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.